Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288019 (US10087178, Example 1) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.10 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288020 (US10087178, Example 2) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.20 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288021 (US10087178, Example 3) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288022 (US10087178, Example 4) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.90 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288023 (US10087178, Example 5) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.90 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288024 (US10087178, Example 6) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288025 (US10087178, Example 7) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288027 (US10087178, Example 8) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.10 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288028 (US10087178, Example 9) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.60 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288029 (US10087178, Example 10) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.60 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288030 (US10087178, Example 11 | US10087178, Example 15) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.80 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288031 (US10087178, Example 12 | US10087178, Example 16) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288032 (US10087178, Example 13) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.40 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288033 (US10087178, Example 14) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.10 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288030 (US10087178, Example 11 | US10087178, Example 15) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.20 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288031 (US10087178, Example 12 | US10087178, Example 16) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.10 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288036 (US10087178, Example 17) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.40 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288037 (US10087178, Example 18) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.60 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288038 (US10087178, Example 19) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.20 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288039 (US10087178, Example 20) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288040 (US10087178, Example 21) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 48 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288041 (US10087178, Example S1 | trans-3-(benzyloxy)-N-(2,...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.70 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288042 (US10087178, Example S2 | cis-3-(benzyloxy)-N-(2,4-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288043 (N-(2,4-difluorobenzyl)- trans-3,9'-dihydroxy-2'- i...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288044 (N-(2,4-difluorobenzyl)-cis- 3,9'-dihydroxy-2'-isop...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.90 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288045 (N-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-tr...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.40 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288046 (N-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-ci...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.70 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288048 (N-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-tr...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.30 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288049 (US10087178, Example S9 | trans-3-(benzyloxy)-N-(2,...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.20 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288050 (US10087178, Example S10 | cis-3-(benzyloxy)-N-(2,4...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.10 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288051 (N-(2,4-difluorobenzyl)- trans-3,9'-dihydroxy-2'- m...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 25 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288052 (N-(2,4-difluorobenzyl)-cis- 3,9'-dihydroxy-2'-meth...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 23 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288053 (N-(2,4-difluorobenzyl)-9'- hydroxy-trans-3-methoxy...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.5 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288055 (US10087178, Example S15 | trans-3-(benzyloxy)-N-(2...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.90 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288056 (US10087178, Example S16 | cis-3-(benzyloxy)-N-(2,4...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.80 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288057 (N-(2,4-difluorobenzyl)-2'- ethyl-trans-3,9'-dihydr...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 20 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288058 (N-(2,4-difluorobenzyl)-2'- ethyl-cis-3,9'-dihydrox...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288059 (N-(2,4-difluorobenzyl)-2'- ethyl-9'-hydroxy-trans-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.80 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288061 (N-(2,4-difluorobenzyl)-cis- 3-ethoxy-2'-ethyl-9'- ...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.80 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288062 (N-(2,4-difluorobenzyl)-9'- hydroxy-cis-3- (hydroxy...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288063 (N-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-ci...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.30 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288064 (N-(2,4-difluorobenzyl)-9'- hydroxy-trans-3- (hydro...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 16 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288065 (N-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-tr...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288067 (N-(3-chloro-2-fluorobenzyl)- cis-3,9'-dihydroxy-2'...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288068 (N-(3-chloro-2-fluorobenzyl)- trans-3-ethoxy-9'-hyd...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.60 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288069 (N-(3-chloro-2-fluorobenzyl)- cis-3-ethoxy-9'-hydro...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.30 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288070 (N7'-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 170 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288071 (N7'-(2,4-difluorobenzyl)-9'- hydroxy-2'-isopropyl-...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288072 (N-(2,4-difluorobenzyl)-9'- hydroxy-trans-3-isoprop...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.60 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein Nef (Human immunodeficiency virus type 1 (isolate BRU/L...) | BDBM288073 (N-(2,4-difluorobenzyl)-9'- hydroxy-cis-3-isopropox...) | PDB MMDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.40 | n/a | n/a | n/a | 25 |
JAPAN TOBACCO INC. US Patent | Assay Description The medium (40 μL), a test substance (10 μL) diluted with the medium, and a 1×105 cells/mL MT-4 cell suspension (50 μL) wherein HIV-1 ... | US Patent US10087178 (2018) BindingDB Entry DOI: 10.7270/Q20C4XSD | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 163 total ) | Next | Last >> |